A repeating geometric pattern of eve biology logo shapes in two shades of muted teal, resembling a wallpaper design.

60 Women. 30 Days. The Numbers

Eve Consumer Trial

SHOP EVE

We didn't ask women to guess whether Eve was working. We measured it.

In a 30-day consumer trial with 60 women aged 45–70 — spanning both perimenopause and menopause — we tracked nine outcomes. Here's what the data showed.

  • A weight loss comparison graphic showing average weight loss of 5.36 lbs, with breakdowns for perimenopause (7.

    Average Weight Loss

  • A digital infographic card showing waist size reduction results for perimenopause and menopause.

    Average Waist Reduction

1 of 2
  • A digital infographic showing a 71% improvement in hot flashes, with progress bars for perimenopause (75%) and menopause (67%) on a white background with a teal border.

    Improvement In Hot Flashes

    Perimenopause 75% Menopause 67%

  • A digital infographic card showing 'Improvement in Energy' at 87.5%, with perimenopause at 75% and menopause at 100%, using dark teal, gray, and red progress bars.

    Improvement In Energy

    Perimenopause 75% Menopause 100%

  • A digital infographic card titled 'Improvement in Brain Fog' showing a large '85%' with percentage improvements for 'Perimenopause' at 87% and 'Menopause' at 83%, including progress bars.

    Improvement In Brain Fog

    Perimenopause 87% Menopause 83%

  • A digital infographic card showing 'Improvement in Bloating' with a 72.5% improvement statistic, breakdowns by perimenopause (87%) and menopause (58%), and progress bars on a white background with a teal border.

    Improvement In Bloating

    Perimenopause 87% Menopause 58%

  • A digital progress card titled 'Anxiety Improvement' with a large '95.5%' and bars showing 'Perimenopause 100%' and 'Menopause 91%'.

    Improvement In Anxiety

    Perimenopause 100% Menopause 91%

1 of 5

Why the Results Differ by Stage

Perimenopause and menopause aren't the same hormonal state — and the results reflect that. Women in perimenopause are still experiencing fluctuating oestrogen, which affects water retention, cortisol response, and metabolic rate differently to post-menopausal women, whose oestrogen has stabilised at a lower baseline.

This is why generic meal replacement shakes — designed for a 30-year-old in a calorie deficit — don't work the same way for women over 45. Eve Biology was formulated with this distinction in mind.

Why These Outcomes Happen

Weight and waist reduction High-quality protein supports muscle retention during a calorie deficit — critical in menopause when muscle loss accelerates. Preserving muscle keeps your metabolic rate higher, making fat loss more sustainable.

Anxiety improvement (95.5%) Ashwagandha KSM-66 — the most clinically studied form of ashwagandha — works directly on the HPA axis, the system that governs your cortisol response. In menopause, chronic HPA activation keeps cortisol elevated, driving anxiety, irritability, and stress sensitivity. KSM-66 has been shown to reduce cortisol levels and support the body's ability to regulate its own stress response — which is why 95.5% of women in our trial reported meaningful improvement in anxiety.

Sleep improvement (85%)
Cortisol and melatonin are inversely related — when cortisol stays elevated into the evening, sleep quality suffers. Ashwagandha KSM-66 supports the body's ability to down-regulate cortisol as the day progresses, helping restore the natural rhythm that menopause disrupts. Better cortisol regulation in the evening means better sleep at night.

Brain fog improvement (85%) Ginkgo Biloba supports cerebral blood flow — increasing the delivery of oxygen and glucose to the brain. In menopause, declining oestrogen reduces cerebrovascular circulation, which is a key driver of brain fog and poor concentration. By supporting blood flow to the brain alongside protein and fibre for blood sugar stability, Eve Biology addresses brain fog from two directions simultaneously.

Hot flashes and night sweats (71%) Hot flashes and night sweats are triggered by the hypothalamus becoming hypersensitive to small changes in body temperature — a direct consequence of falling oestrogen. Ashwagandha KSM-66 helps regulate the HPA axis and reduce the cortisol spikes that amplify thermoregulatory sensitivity, making the hypothalamus less reactive. Results vary by hormonal stage — which is why the peri/menopause split in our trial reflects a meaningful difference in response.

Bloating improvement (72.5%) Eve Biology contains Actilight® — a clinically proven prebiotic fibre with a short-chain structure (DP 3-5) that selectively stimulates the growth of bifidobacteria in the gut, even at a low dose of 2.5g per day. In menopause, falling oestrogen reduces gut microbiome diversity, disrupting digestion and driving bloating. Actilight® directly addresses this by rebalancing gut microbiota, improving bowel function and gastrointestinal comfort — without the artificial sweeteners and fillers that commonly aggravate symptoms in other shakes.

Energy improvement (87.5%) Sustained energy in menopause depends on more than avoiding a calorie deficit. Eve Biology supports energy production directly — with iron and a full B vitamin complex to fuel cellular energy pathways — while Actilight® prebiotic fibre improves nutrient absorption in the gut, meaning the vitamins and minerals you consume are actually extracted and used. Ashwagandha KSM-66 addresses the cortisol-driven fatigue that disrupts sleep and depletes the adrenal system. The result is energy supported at three levels: production, absorption, and recovery — without stimulants.

About the Trial

60 women aged 45–70, split across perimenopause and post menopause stages, completed a 30-day consumer trial replacing breakfast and lunch with The Rebalancing Shake Monday to Friday for 4 weeks. Outcomes were self-reported at day 0 and day 30 across nine symptom and body composition measures. We wanted to keep the trial realistic. We didn't ban alcohol or treats. We did encourage women to do 30 minutes walking a day as a minimum activity benchmark.

How We Measured It

At day 0 and day 30, each participant completed a structured self-assessment covering:

  • Body composition — weight, waist circumference, and height recorded at both intervals
  • Eight symptoms — anxiety, brain fog, hot flashes, sleep disruption, night sweats, PMT, energy, and bloating — each rated on a five-point severity scale from "I don't suffer from this" to "severe, causing significant disruption to daily life"
  • Digestive health — bowel movement frequency as a gut health indicator
  • Context — menopause stage (peri or menopause), HRT use, and prior shake experience

Results were anonymised and analysed by stage. The severity scale allowed us to measure meaningful improvement even where symptoms didn't disappear entirely — a reduction from severe to mild is a real outcome.

30 Day Baseline Tracker

Build your baseline profile - we'll send you a copy to keep. In 30 days we'll send you a reminder to add your current stats to the profile. That way, whatever it is you've been doing you'll know what's changing.

LOG MY BASELINE
  • Woman in athletic wear with text about perimenopausal symptoms reduction

    Review -Ann B

  • Happy customer holding a chocolate shake

    Review - Jean A

  • Woman in wetsuit with text overlay about Eve Biology shakes and Anna McKibben's testimonial.

    Review - Anna M

1 of 3

On The Trial Women Just Had The Shake

Todays Eve Biology Customers Get More

When 60 women completed our consumer trial, they had one thing: The Rebalancing Shake.

No nutritionist-designed recipes. No meal guides. No support programme.

The results you've seen above were achieved with the shake alone.

Since the trial, we've built out everything we wished those women had access to — because we saw what was possible without it, and we wanted to know what happens when women are properly supported.

Every Eve Biology customer now gets:

The trial set the baseline. What you're starting with is the full picture.

Frequently Asked Questions

How much weight did women lose in the Eve Biology trial? 

On average, women lost 5.36 lbs over 30 days. Women in perimenopause lost an average of 7.3 lbs, while women in menopause lost an average of 3.43 lbs.

Who took part in the Eve Biology trial? 

Women aged 45–70, spanning both perimenopause and menopause, completed a 30-day consumer trial using The Rebalancing Shake as a daily meal replacement. Our volunteers were friends of friends, some colleagues and referrals.

Did the Eve Biology shake help with menopause symptoms?

Yes. In a 30-day consumer trial, 95.5% of women reported improvement in anxiety, 85% reported improvement in brain fog and sleep, 71% reported improvement in hot flashes and night sweats, and 87.5% reported improvement in energy levels.

Why are the results different for perimenopause and menopause? 

The 4-week structure is a starting point. Many women continue with one shake a day indefinitely as part of a balanced diet — that's a healthy, sustainable approach.

Is this safe during perimenopause or menopause?

Perimenopause and menopause involve different hormonal states. Women in perimenopause are still experiencing fluctuating oestrogen, which affects water retention, cortisol response, and metabolism differently to post-menopausal women. This is why results vary by stage.

How does The Rebalancing Shake help with bloating? 

72.5% of women in the trial reported improvement in bloating. Eve Biology contains Actilight® — a clinically proven prebiotic fibre that selectively stimulates the growth of bifidobacteria in the gut. Falling oestrogen reduces gut microbiome diversity, which contributes to bloating. Actilight® directly rebalances gut microbiota to improve gastrointestinal comfort.

 Is the Eve Biology trial clinically proven? 

The results come from a 30-day consumer trial with 50 women aged 45–70, with outcomes self-reported at day 0 and day 30. While not a clinical study, the trial was structured to measure real-world outcomes across nine symptom and body composition measures.

Ready To Try It?

The trial used The Rebalancing Shake — available in Chocolate, Vanilla, and Strawberry.

SHOP EVE